Association between plasma rituximab concentration and the risk of major relapse in antineutrophil cytoplasmic antibody-associated vasculitides during rituximab maintenance therapy.

Nihel Khoudour,Florence Delestre,Fabienne Jabot-Hanin,Anne Jouinot,Juliette Nectoux,Franck Letouneur, Brigitte Izac,Michel Vidal,Loïc Guillevin,Xavier Puéchal,Pierre Charles,Benjamin Terrier,Benoit Blanchet

Arthritis & rheumatology (Hoboken, N.J.)（2023）

引用 0|浏览3

暂无评分

摘要

These results suggest that drug monitoring could be useful to individualize the schedule of rituximab administration within the maintenance phase. This article is protected by copyright. All rights reserved.

查看译文

关键词

plasma rituximab concentration,antineutrophil cytoplasmic antibody–associated,antibody–associated vasculitides

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要